Company Profiles

driven by the PitchBook Platform

Viamet Pharmaceuticals

Description

Developer of pharmaceuticals. The company is a biopharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology platform. Its clinical portfolio includes novel agents to treat chronic and life-threatening diseases.

2004

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$12M

Latest Deal Amount

$168M

Total Amount Raised

Description

Developer of pharmaceuticals. The company is a biopharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology platform. Its clinical portfolio includes novel agents to treat chronic and life-threatening diseases.

Website:

www.viamet.com

Formerly Known As

Hephistics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

4505 Emperor Boulevard Suite 300 Durham, NC 27703United States +1 (919) 467-8539
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Viamet Pharmaceuticals's full profile, request a free trial.

Viamet Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Viamet Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Viamet Pharmaceuticals Investors (10)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
A&B Equity HoldingsOtherMinority000 0000000 0000
Astellas Venture ManagementCorporate Venture CapitalMinority000 0000000 0000
Brandon Point IndustriesOtherMinority000 0000000 0000
Hatteras Venture PartnersVenture CapitalMinority000 0000000 0000
Headland VenturesVenture CapitalMinority000 0000000 0000
A&B Equity Holdings Other
Astellas Venture Management Corporate Venture Capital
Brandon Point Industries Other
Hatteras Venture Partners Venture Capital
Headland Ventures Venture Capital

Viamet Pharmaceuticals Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Amir Tavakkol Ph.DChief Development Officer
Volker Herrmann MDChief Commercial Officer
Ed Garvey Ph.DVice President, Biology
Stephen Brand Ph.DVice President, Clinical Development
Neil MooreVice President, Commercial Operations
Amir Tavakkol Ph.D Chief Development Officer
Volker Herrmann MD Chief Commercial Officer
Ed Garvey Ph.D Vice President, Biology
Stephen Brand Ph.D Vice President, Clinical Development
Neil Moore Vice President, Commercial Operations

Viamet Pharmaceuticals Board Members (12)

NameRepresentingRoleSinceContact
Info
Adrian Howd Ph.DSelfBoard Member000 0000
Andrew von Eschenbach MDSelfBoard Member000 0000
Douglas Reed MDHatteras Venture PartnersGeneral Partner000 0000
James RosenIntersouth PartnersPartner000 0000
Jeffrey EdwardsViamet PharmaceuticalsBoard Member000 0000
Adrian Howd Ph.D Board Member Self
Andrew von Eschenbach MD Board Member Self
Douglas Reed MD General Partner Hatteras Venture Partners
James Rosen Partner Intersouth Partners
Jeffrey Edwards Board Member Viamet Pharmaceuticals
Request full access to PitchBook